Magnus Ingelman Sundberg's Biography

Magnus Ingelman Sundberg, Professor/Head, Karolinska Institutet

Magnus Ingelman-Sundberg is a PhD and BSc.Med. He is Chairman of the Editorial Board of Pharmacogenetics and Genomics and Chairman of the Microsomes and Drug Oxidation organisation. He has been working with pharmacogenomics at EMA (PGWP) since 2005. He has 350 original papers, 17 500 citations and an h-factor of 72. He is ranked as the 4th most highly impact researcher in the field of drug metabolism (www.cytochrome.net ) and one of the worlds most cited authors within the category Pharmacology http://isihighlycited.com/ . The current research is centered about genetic predictors for drug response and adverse drug reactions.

Pharmacogenomic and Pharmacoepigenomic Biomarkers for Drug Efficacy and Toxicity

Wednesday, 19 February 2014 at 15:00

Add to Calendar ▼2014-02-19 15:00:002014-02-19 16:00:00Europe/LondonPharmacogenomic and Pharmacoepigenomic Biomarkers for Drug Efficacy and ToxicityADME and Predictive Toxicology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

The lecture will be focused on: Genetic bases for interindividual differences in drug metabolism and effects. Important genetic and epigenetic factors determining adverse drug reactions. The role of new regulatory RNA species for regulation of ADME genes. Modification of histones and, in addition, expression of ncRNAs such as microRNAs. The use of pharmacogenomic biomarkers for prediction of the outcome of drug therapy. Use of epigenetic modifications for monitoring progress of e.g. tumor treatment.

Add to Calendar ▼2014-02-18 00:00:002014-02-19 00:00:00Europe/LondonADME and Predictive ToxicologyADME and Predictive Toxicology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors